ReCerise Therapeutics Inc. ("ReCerise"), a company committed to research and development of first-in-class therapeutics in oncology, recently entered a research partnership with the National Cancer ...

ReCerise Therapeutics Inc. ("ReCerise"), a company committed to research and development of first-in-class therapeutics in oncology, recently entered a research partnership with the National Cancer ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

Vision changes are an inevitable part of aging, but why are some more susceptible to age-related eye diseases and why do some ...

Extraordinary funding from the Chan Zuckerberg Initiative supports two large collaborative projects that will boost imaging technology development ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

From understanding hereditary diseases to predicting drug responses, sequencing helps researchers uncover the subtle language ...

A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health ...

Unveiled today, the Pyxa platform enables researchers to visualize and analyze the spatial organization of cells and ...

Researchers discover that bone marrow cancer cells diversify drastically when exiting the bone marrow, which also affects the ...

Gilberto Barcellos and Dr. Melanie Bailey discuss the growing interest in single-cell lipidomics, the key challenges ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...